Mutation of cancer driverMLL2results in transcription stress and genome instability

Genes and Development - Tập 30 Số 4 - Trang 408-420 - 2016
Theodoros Kantidakis1, Marco Saponaro1, Richard Mitter2, Stuart Horswell2, Andrea Kranz3, Stefan Boeing1, Ozan Aygün1, Gavin Kelly2, Nik Matthews4, Aengus Stewart2, Jesper Q. Svejstrup1
11Mechanisms of Transcription Laboratory, Clare Hall Laboratories, The Francis Crick Institute, South Mimms EN6 3LD, United Kingdom
22Bioinformatics and Biostatistics Group, The Francis Crick Institute, London WC2A 3LY, United Kingdom
33Biotechnologisches Zentrum, Technische Universität Dresden, 01062 Dresden, Germany
44Advanced Sequencing Facility, The Francis Crick Institute, London WC2A 3LY, United Kingdom

Tóm tắt

Genome instability is a recurring feature of tumorigenesis. Mutation inMLL2, encoding a histone methyltransferase, is a driver in numerous different cancer types, but the mechanism is unclear. Here, we present evidence thatMLL2mutation results in genome instability. Mouse cells in whichMLL2gene deletion can be induced display elevated levels of sister chromatid exchange, gross chromosomal aberrations, 53BP1 foci, and micronuclei. HumanMLL2knockout cells are characterized by genome instability as well. Interestingly, MLL2 interacts with RNA polymerase II (RNAPII) and RECQL5, and, althoughMLL2mutated cells have normal overall H3K4me levels in genes, nucleosomes in the immediate vicinity of RNAPII are hypomethylated. Importantly,MLL2mutated cells display signs of substantial transcription stress, and the most affected genes overlap with early replicating fragile sites, show elevated levels of γH2AX, and suffer frequent mutation. The requirement for MLL2 in the maintenance of genome stability in genes helps explain its widespread role in cancer and points to transcription stress as a strong driver in tumorigenesis.

Từ khóa


Tài liệu tham khảo

10.1038/nrg2268

10.1016/j.dnarep.2009.12.008

10.1073/pnas.0804424105

10.1038/ng.2799

10.1016/j.cell.2013.01.006

10.1016/j.molcel.2012.03.001

10.1242/dev.098152

10.1038/nature11404

10.1186/gb-2006-7-10-r100

10.1016/j.molcel.2014.02.032

10.1038/nature08672

10.1016/j.cell.2013.07.032

10.1038/nature11247

10.1038/ng.3076

10.1038/nmeth.2642

10.1038/nature11125

10.1073/pnas.1208807109

10.18632/oncotarget.1555

10.1016/j.cell.2011.02.013

10.1038/nsmb.2543

10.1101/gad.201327.112

10.1016/j.molcel.2014.02.033

10.1128/MCB.01181-13

10.1038/ncomms4630

10.1038/emboj.2010.38

10.1128/MCB.01506-06

10.1002/path.4203

10.18632/oncotarget.653

10.1038/nrg3152

10.1073/pnas.0902873106

10.7554/eLife.01503

10.1038/nature09745

10.1016/j.exphem.2014.09.006

10.1016/0027-5107(83)90068-4

10.1182/blood-2013-05-500264

2001, A mutator phenotype in cancer, Cancer Res, 61, 3230

10.1073/pnas.1121343109

10.1038/ncb2201

10.1038/sj.emboj.7601719

10.1182/blood-2013-02-483727

10.1038/ng.2856

10.1126/science.1198056

10.1038/ng.892

10.1038/nature11329

10.1074/jbc.273.10.5858

10.1136/jclinpath-2014-202447

10.1007/s13238-014-0031-6

10.1016/j.molcel.2006.12.014

10.1038/nature13483

10.1016/j.cell.2014.03.048

10.1158/1078-0432.CCR-13-3310

10.1146/annurev.biochem.78.062807.091425

10.1093/nar/gks287

10.1038/nature13176

10.1038/nature11017

10.1016/j.tibs.2007.02.005

10.1016/j.tibs.2010.02.001

2014, Examining the impact of gene variants on histone lysine methylation, Biochim Biophys Acta, 1839, 1463, 10.1016/j.bbagrm.2014.05.014

10.1038/nrm3941

2014, Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients, Sci Rep, 4, 6036, 10.1038/srep06036